| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/06/2011 | WO2011123393A1 Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 10/06/2011 | WO2011123180A1 Medical devices including medicaments and methods of making and using same |
| 10/06/2011 | WO2011122934A2 Bioencapsule and method thereof |
| 10/06/2011 | WO2011122926A1 A drug delivery system in bone tissue |
| 10/06/2011 | WO2011122923A2 Long-acting interferon beta formulation using immunoglobulin fragment |
| 10/06/2011 | WO2011122922A2 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment |
| 10/06/2011 | WO2011122921A2 An insulin conjugate using an immunoglobulin fragment |
| 10/06/2011 | WO2011122620A1 Pharmaceutical preparation comprising phenylalanine derivative |
| 10/06/2011 | WO2011122524A1 Controlled release pharmaceutical composition |
| 10/06/2011 | WO2011122523A1 Controlled release pharmaceutical composition |
| 10/06/2011 | WO2011122477A1 Vesicle-containing composition |
| 10/06/2011 | WO2011121833A1 Water-soluble iron supply agent with reducing power and with coffee grounds or tea dregs as raw material |
| 10/06/2011 | WO2011121824A1 Orally disintegrating tablet |
| 10/06/2011 | WO2011121823A1 Particulate pharmaceutical composition for oral administration |
| 10/06/2011 | WO2011121604A2 A liquid vaginal spray formulation for treatment of vaginal fungal infection |
| 10/06/2011 | WO2011121559A2 Stabilized antibody preparations and uses thereof |
| 10/06/2011 | WO2011121515A1 Spray-dried crystalline active ingredient |
| 10/06/2011 | WO2011121496A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration |
| 10/06/2011 | WO2011121475A2 Modified release dosage form comprising desvenlafaxine or salts thereof |
| 10/06/2011 | WO2011121425A1 Pharmaceutical powder composition for inhalation |
| 10/06/2011 | WO2011121305A2 Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| 10/06/2011 | WO2011121082A1 Bioadhesive compositions of local anaesthetics |
| 10/06/2011 | WO2011121074A1 Thermogelling anaesthetic compositions |
| 10/06/2011 | WO2011121034A2 Water-free pharmaceutical compositions suitable for local anaesthetics |
| 10/06/2011 | WO2011121019A2 Method for producing a drug delivery system on the basis of polyelectrolyte complexes |
| 10/06/2011 | WO2011120925A1 Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis |
| 10/06/2011 | WO2011120904A2 A fast dissolving pharmaceutical composition |
| 10/06/2011 | WO2011120903A2 A fast dissolving pharmaceutical composition |
| 10/06/2011 | WO2011120779A1 Process for preparing carrier particles for dry powders for inhalation |
| 10/06/2011 | WO2011120704A1 Transdermal patch containing 17-deacetyl norgestimate |
| 10/06/2011 | WO2011120530A1 Porous tablets as carriers for liquid formulations |
| 10/06/2011 | WO2011120427A1 Insecticide composition and method of controlling insects using the same |
| 10/06/2011 | WO2011120339A1 Microemulsion formulation containing arctigenin |
| 10/06/2011 | WO2011120281A1 Use of l-oxiracetam in manufacture of medicaments for preventing or treating cognitive dysfunction |
| 10/06/2011 | WO2011120155A1 Supercritical fluid treatment of high molecular weight biopolymers |
| 10/06/2011 | WO2011120084A1 Transdermal delivery patch |
| 10/06/2011 | WO2011120070A1 Transdermal delivery patch |
| 10/06/2011 | WO2011094608A3 Two-wrist data gathering system |
| 10/06/2011 | WO2011089619A3 Method and balloon catheter assembly for treating bifurcation lesions |
| 10/06/2011 | WO2011089234A3 Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease |
| 10/06/2011 | WO2011077452A3 Fast dissolving pharmaceutical composition comprising lornoxicam |
| 10/06/2011 | WO2011077451A3 Controlled release pharmaceutical composition |
| 10/06/2011 | WO2011066970A3 Transdermal therapeutic system for the administration of peptides |
| 10/06/2011 | WO2011066291A3 Lyophilization methods, compositions, and kits |
| 10/06/2011 | WO2011066260A3 Formulations comprising aminosterols |
| 10/06/2011 | WO2011063164A3 Sustained release cannabinoid medicaments |
| 10/06/2011 | WO2011062906A9 Treatment of atrial fibriallation |
| 10/06/2011 | WO2011061519A3 Topical foam composition |
| 10/06/2011 | WO2011053917A3 Gastroretentive oral high dose zinc preparations |
| 10/06/2011 | WO2011050357A3 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer |
| 10/06/2011 | WO2011044533A3 Coating system and method for drug elution management |
| 10/06/2011 | WO2011041451A3 Smoking cessation with body weight maintenance and nutritional supplement |
| 10/06/2011 | WO2011035279A3 Nanocarriers for imaging and therapy applications |
| 10/06/2011 | WO2011031996A3 Engineered microparticles for macromolecule delivery |
| 10/06/2011 | WO2011031553A3 Implantable device for production of interleukin-1 receptor antagonist |
| 10/06/2011 | WO2011019956A3 Pharmaceutical compositions with tetrabenazine |
| 10/06/2011 | WO2011016057A3 Controlled release pharmaceutical compositions of milnacipran |
| 10/06/2011 | WO2010111221A4 Compositions and methods for preferential distribution of active agents to injury sites |
| 10/06/2011 | WO2010107482A3 Germicidal composition |
| 10/06/2011 | US20110245914 Stent having active release reservoirs |
| 10/06/2011 | US20110245784 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 10/06/2011 | US20110245663 Automatic Liquid Injection System and Method |
| 10/06/2011 | US20110245493 Delivery of drug amines through an inhalation route |
| 10/06/2011 | US20110245332 Injectable formulations of taxanes for cad treatment |
| 10/06/2011 | US20110245300 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 10/06/2011 | US20110245299 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 10/06/2011 | US20110245298 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 10/06/2011 | US20110245202 Pharmaceutical composition for the treatment of rhinitis |
| 10/06/2011 | US20110245177 Method for topical treatment of eye disease and composition and device for said treatment |
| 10/06/2011 | US20110244695 Uv-curable inorganic-organic hybrid resin and method for preparation thereof |
| 10/06/2011 | US20110244051 Pharmaceutical formulations for the treatment of overactive bladder |
| 10/06/2011 | US20110244050 Pulsed-release sildenafil composition and method for preparing said composition |
| 10/06/2011 | US20110244049 Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same |
| 10/06/2011 | US20110244048 Multifunctional self-assembling polymeric nanosystems |
| 10/06/2011 | US20110244047 Film-form preparation and method for producing the same |
| 10/06/2011 | US20110244046 Charge Reversible Polymers |
| 10/06/2011 | US20110244045 Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation |
| 10/06/2011 | US20110244044 Compound, medicament, vaccine composition and nanocapsules |
| 10/06/2011 | US20110244043 Controlled releasing composition |
| 10/06/2011 | US20110244042 Stabilized formulations of cns compounds |
| 10/06/2011 | US20110244041 Plant extract hydrolysates and antibacterial product containing the same |
| 10/06/2011 | US20110244040 Film-coated scored tablet |
| 10/06/2011 | US20110244039 Absorbable solid compositions for topical treatment of oral mucosal disorders |
| 10/06/2011 | US20110244038 Berry preparations and extracts |
| 10/06/2011 | US20110244037 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 10/06/2011 | US20110244036 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 10/06/2011 | US20110244035 Dosage Forms |
| 10/06/2011 | US20110244034 Sustained release drug delivery system |
| 10/06/2011 | US20110244033 Tamsulosin pellets for fixed dose combination |
| 10/06/2011 | US20110244032 Dispersible phospholipid stabilized microparticles |
| 10/06/2011 | US20110244031 Porous tablets as carriers for liquid formulations |
| 10/06/2011 | US20110244030 Topical foaming compositon and method of application |
| 10/06/2011 | US20110244029 Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same |
| 10/06/2011 | US20110244028 Method of solubilizing biologically active compounds |
| 10/06/2011 | US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections |
| 10/06/2011 | US20110244026 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| 10/06/2011 | US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity |
| 10/06/2011 | US20110244024 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 10/06/2011 | US20110244023 Transdermal delivery patch |
| 10/06/2011 | US20110244022 Transdermal delivery patch |